Nov 13 (Reuters)- Kidswell Bio Corporation CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 6 months ended 6 months ended Year to Sep 30, 2025 Sep 30, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 3.28 1.75 (+87.2 pct) Operating 215 mln loss 262 mln Recurring 76 mln loss 267 mln Net 60 mln loss 241 mln EPS 1.26 yen loss 6.09 yen EPS Diluted 1.23 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Kidswell Bio Corporation. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T